← Eichor
Study identifier: NCT07403630 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP)

Condition: Acute Leukemia · Multiple Myeloma · Squamous Cell Carcinoma  ·  Sponsor: Azienda Ospedaliero-Universitaria di Parma

PhaseNA
Planned participants300
Who can joinAll sexes, 1 Year to no upper limit
Healthy volunteersNo

About this study

This is a multicenter, experimental preclinical study conducted on primary samples from patients diagnosed with hematological or solid neoplasms defined as high risk. The study will be prospective, based on the consecutive enrollment of eligible patients at each participating institution.

This description comes directly from the study's public registry record.

Talk to the study team

Giovanni Roti, Associate Professor  ·  +39 0521 702200  ·  giovanni.roti@unipr.it

Always discuss trial participation with your own doctor first.

Locations (2)

AO Riuniti Villa Sofia-Cervello di PalermoPalermo, Palermo, ItalyRecruiting
University of PerugiaPerugia, Perugia, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07403630